NIH Privately Funds Next Wave of Syphilis Research Innovations
Published Date: 3/17/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed video meeting on April 8, 2025, to review special grant applications focused on innovative research about syphilis. This meeting affects researchers applying for funding and keeps sensitive info private. No public access means the grant decisions will be made behind the scenes, helping protect personal and patent details.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed NIH review of syphilis grant applications
If you applied for the NIAID R21 grant "Promoting Innovative Research in Treponema Pallidum Pathogenesis (R21 Clinical Trial Not Allowed)", your application will be reviewed in a meeting closed to the public on April 8, 2025, from 10:00 a.m. to 6:00 p.m. The video-assisted meeting at NIAID in Rockville, MD will review and evaluate grant applications and keep discussions of confidential trade secrets, patentable material, and personal information private.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-12844 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings on July 17, 2026, to review important grant applications. These meetings protect private info and trade secrets while deciding which science projects get funding. Researchers applying for grants in brain injury, neurobehavior, nanotech, and heart/lung studies should note these review dates and prepare accordingly.
2026-12843 — Government Owned Inventions Available for License: C8166-45 Cell Line
The National Cancer Institute is offering a special human T-cell line called C8166-45 for licensing. This cell line helps scientists study viruses like HTLV-1 and HIV, which can cause serious diseases. Researchers and companies can now use this tool to develop better treatments, with licensing info available starting June 2026—no patents, just pure science power ready to roll!
2026-12842 — Government Owned Inventions Available for License: Compositions and Methods for Producing Dendritic Cell-based Vaccines With Enhanced Efficacy
The National Cancer Institute has created a new way to make cancer vaccines stronger by using special omega-3 fats to boost immune cells called dendritic cells. This could help scientists and companies develop better cancer treatments that work more effectively. If you’re in biotech or medicine, now’s the time to team up or license this exciting technology and help bring improved vaccines to patients faster.
2026-12585 — Submission for OMB Review; 30-Day Comment Request; Chimpanzee Research Use Form (Office of the Director)
The NIH wants to keep collecting info using the Chimpanzee Research Use Form and is asking the public to share thoughts by July 23, 2026. This form helps track how chimpanzees are used in research, affecting scientists and animal welfare groups. No big changes or costs are expected, just a smooth extension of the current form’s approval.
2026-12565 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for cool science projects. If you’re a researcher waiting on grants, these reviews shape the future of your funding and the science world!
2026-12244 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
Previous / Next Documents
Previous: 2025-04213 — National Cancer Institute; Notice of Closed Meetings
The National Cancer Institute is holding several closed virtual meetings in April 2025 to review and decide on grant applications for cancer research funding. These meetings protect private info and trade secrets while helping decide who gets money to fight cancer. If you’re applying for a grant, these dates are key for your funding chances!
Next: 2025-04216 — National Cancer Institute; Notice of Closed Meetings
The National Cancer Institute is holding private virtual meetings in April 2025 to review and decide on grant applications for small business research funding. These closed sessions protect sensitive info like trade secrets and personal details. If you’re applying for these grants, expect decisions soon that could impact funding and research timelines.